[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Immunology](https://durgical.com/en/immunology/) › [Adaptive immunity](https://durgical.com/en/immunology/areas/adaptive/) › T-cell receptor signalling and the immune synapse (where drugs act)

# T-cell receptor signalling and the immune synapse (where drugs act)

- Process

When a T cell recognises its antigen, a chain of enzymes carries the message to the nucleus to make [IL-2](https://durgical.com/en/pharmacology/aldesleukin/); transplant drugs cut this chain at specific links.

Updated Nov 15, 2026

## Key points

- Lck → ZAP-70 → LAT/SLP-76 → PLCγ → [Ca²⁺](https://durgical.com/en/biochemistry/topics/calcium-and-phosphate/) /calcineurin/NFAT + DAG/PKC/NF-κB + Ras/AP-1 → IL-2.
- [Calcineurin inhibitors](https://durgical.com/en/pharmacology/classes/calcineurin-inhibitors/) stop IL-2 [transcription](https://durgical.com/en/biochemistry/topics/transcription/); [mTOR inhibitors](https://durgical.com/en/pharmacology/classes/mtor-inhibitors/) stop the response to IL-2.
- ZAP-70 deficiency → no CD8 T cells, CD4 present but non-functional.
- [Abatacept](https://durgical.com/en/pharmacology/abatacept/) / [belatacept](https://durgical.com/en/pharmacology/belatacept/) block B7–CD28 (signal 2).

## What it is

Antigen recognition by the T-cell receptor is converted into gene activation by a cascade of kinases, adaptors and [second messengers](https://durgical.com/en/physiology/cell-signaling-for-physiology/). The contact zone between T cell and antigen-presenting cell becomes an organised immune synapse. The pathway ends in three transcription factors, NFAT, NF-κB and AP-1, that switch on IL-2 and other genes. Calcineurin inhibitors, mTOR inhibitors and costimulation blockers act at defined steps, and inherited defects in the pathway cause combined immunodeficiency.

## How to think about it

Picture the TCR signal as a relay with three runners leaving the membrane, calcium (to calcineurin and NFAT), DAG (to PKC and NF-κB) and Ras (to AP-1), who must all reach the IL-2 gene together. Drugs remove a runner or a later leg: calcineurin inhibitors stop IL-2 being made, mTOR inhibitors stop cells obeying IL-2, and costimulation blockers stop signal 2 before the race starts.

## Key facts

- Immune synapse: TCR and CD28 cluster in the centre (cSMAC), LFA-1–ICAM-1 adhesion forms a ring around them (pSMAC).
- [Cyclosporine](https://durgical.com/en/pharmacology/ciclosporin/) and [tacrolimus](https://durgical.com/en/pharmacology/tacrolimus/) bind different proteins (cyclophilin, FKBP12) but both inhibit calcineurin.
- [Sirolimus](https://durgical.com/en/pharmacology/sirolimus/) binds FKBP12 like tacrolimus, but the complex inhibits [mTOR](https://durgical.com/en/biochemistry/enzymes/mtor/) instead of calcineurin.
- Tacrolimus is a calcineurin inhibitor that is a frequent cause of post-transplant diabetes; cyclosporine causes gingival overgrowth and [hirsutism](https://durgical.com/en/obstetrics-gynaecology/hirsutism-and-hyperandrogenism/).

## Step by step

- TCR binds peptide–MHC; CD4 or CD8 binds the same MHC and brings the kinase Lck.
- Lck phosphorylates ITAMs on CD3 and ζ chains; the kinase ZAP-70 docks there and is activated.
- ZAP-70 phosphorylates the adaptors LAT and SLP-76, which recruit PLCγ1 and Ras activators.
- PLCγ1 makes IP3 (calcium release → calcineurin → NFAT enters the nucleus) and DAG (PKCθ → NF-κB).
- Ras–MAP kinase signalling produces AP-1; NFAT, NF-κB and AP-1 together switch on IL-2.
- CD28 binding B7 adds PI3K–Akt–mTOR signals for survival, metabolism and proliferation.
- IL-2 binds its receptor and, through JAK–STAT and mTOR, drives clonal expansion.

## Drugs and defects along the pathway

| Step | Drug or defect | Effect |
| --- | --- | --- |
| B7–CD28 costimulation | Abatacept, belatacept (CTLA-4–Ig) | Block signal 2; used in RA and [kidney transplant](https://durgical.com/en/conditions/kidney-transplantation-and-the-kidney-transplant-recipient/) |
| Calcineurin → NFAT | Cyclosporine (with cyclophilin), tacrolimus (with FKBP12) | No NFAT, little IL-2; nephrotoxicity, hypertension, neurotoxicity |
| mTOR | Sirolimus, [everolimus](https://durgical.com/en/pharmacology/everolimus/) (with FKBP12) | Block response to IL-2 and proliferation; impaired wound healing, hyperlipidaemia |
| IL-2 receptor α (CD25) | [Basiliximab](https://durgical.com/en/pharmacology/basiliximab/) | Induction therapy in transplantation |
| ZAP-70 | Inherited ZAP-70 deficiency | Absent CD8 cells, non-functional CD4 cells: combined immunodeficiency |
| Lck, CD3 chains | Rare inherited defects | Combined immunodeficiency |

## Common traps

- **Tacrolimus and sirolimus act alike because both bind FKBP12**: the tacrolimus complex blocks calcineurin, while the sirolimus complex blocks mTOR.
- **Cyclosporine blocks the IL-2 receptor signal**: it blocks IL-2 transcription through calcineurin–NFAT; blocking the response to IL-2 is what mTOR inhibitors do.
- **ZAP-70 deficiency means no T cells**: CD4 cells are present but non-functional and CD8 cells are absent, so total lymphocytes can look normal.
- **Abatacept is an anti-CD28 antibody**: it is CTLA-4–Ig, a fusion protein that grabs B7 (CD80/CD86) so CD28 receives no signal 2.

## Test yourself

Think of the answer, then tap the question to see it.

## Which phosphatase do cyclosporine and tacrolimus inhibit, and which transcription factor stays out of the nucleus?

Calcineurin; NFAT stays phosphorylated in the cytoplasm, so IL-2 is not transcribed.

## Why can sirolimus be combined with a calcineurin inhibitor without simply duplicating it?

They hit different steps: calcineurin inhibitors stop IL-2 being transcribed, while sirolimus blocks mTOR signals downstream of the IL-2 receptor and other growth signals.

## An infant with severe infections has normal CD4 counts but no CD8 T cells, and the CD4 cells do not proliferate to antigen. Which kinase is defective?

ZAP-70, recruited to phosphorylated CD3/ζ ITAMs; without it TCR signals fail, and CD8 cells are lost during thymic selection.

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/immunology/t-cell-receptor-signalling-and-the-immune-synapse/)

## Connections

## Related 8

- [T-cell activation: two signals and superantigens](https://durgical.com/en/immunology/t-cell-activation-two-signals-and-superantigens/)
- [Fc receptors, BCR and TCR](https://durgical.com/en/immunology/fc-receptors-bcr-and-tcr/)
- [Immunosuppressants by mechanism (classes)](https://durgical.com/en/immunology/immunosuppressants-by-mechanism/)
- [Interleukin-2](https://durgical.com/en/immunology/interleukin-2/)
- [Adhesion molecules: selectins and integrins](https://durgical.com/en/immunology/adhesion-molecules-selectins-and-integrins/)
- [Transplant rejection: hyperacute, acute, chronic](https://durgical.com/en/immunology/transplant-rejection-hyperacute-acute-chronic/)
- [T-cell and combined deficiencies: DiGeorge, SCID, Wiskott–Aldrich, ataxia-telangiectasia](https://durgical.com/en/immunology/t-cell-and-combined-deficiencies-digeorge-scid-wiskott-aldrich-ataxia-telangiect/)
- [Common γ-chain cytokines (IL-2, 4, 7, 9, 15, 21) and X-SCID](https://durgical.com/en/immunology/common-chain-cytokines-and-x-scid/)

## Related conditions 2

- [Kidney transplant rejection](https://durgical.com/en/conditions/kidney-transplant-rejection/)
- [Rheumatoid arthritis](https://durgical.com/en/conditions/rheumatoid-arthritis/)

## In Pharmacology 5

- [Calcineurin inhibitors](https://durgical.com/en/pharmacology/classes/calcineurin-inhibitors/)
- [Tacrolimus](https://durgical.com/en/pharmacology/tacrolimus/)
- [mTOR inhibitors](https://durgical.com/en/pharmacology/classes/mtor-inhibitors/)
- [Sirolimus](https://durgical.com/en/pharmacology/sirolimus/)
- [Abatacept](https://durgical.com/en/pharmacology/abatacept/)

[← All of immunology](https://durgical.com/en/immunology/)

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: [Tacrolimus](https://medlineplus.gov/druginfo/meds/a601117.html) (MedlinePlus, US National Library of Medicine, 2024); [Transplant rejection](https://medlineplus.gov/ency/article/000815.htm) (MedlinePlus, US National Library of Medicine, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/immunology/t-cell-receptor-signalling-and-the-immune-synapse/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/immunology/t-cell-receptor-signalling-and-the-immune-synapse/
